The Foodand DrugAdministration approved Pfizer's Hympavzi to prevent or reduce bleeding episodes in patients with certain kinds of hemophilia, the pharmaceutical company said. Write to Rob ...
(RTTNews) - Pfizer Inc. (PFE) announced Friday that the U.S. Foodand DrugAdministration has approved HYMPAVZI (marstacimab-hncq) for routine prophylaxis to prevent or reduce the frequency of ...
Some results have been hidden because they may be inaccessible to you